PV-1: a novel molecular prognostic marker of distant metastases in various solid tumors
Open Access
- 21 July 2025
- journal article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (9) , 2215-2232
Abstract
Identification of biomarkers for the hematogenous spreading of cancer cells is of paramount prognostic and therapeutic value. We showed that Plasmalemma Vesicle Associated Protein-1 (PV-1) serves as a marker of increased blood vessel permeability and is an independent predictor of colorectal cancer dissemination. This study investigates whether PV-1 can also act as a prognostic marker for distant metastases in other solid tumors. We analyzed samples from 134 patients: 30 luminal breast cancer (BC), 52 clear cell renal cell carcinoma (ccRCC), and obtained preliminary data from 52 soft tissue sarcomas (STS). A higher frequency of PV-1+ endothelial cells was significantly associated with metastatic progression in luminal BC and ccRCC. Moreover, the frequency of PV-1+ cells emerged as a significant prognostic factor for metastasis-free survival in both luminal BC and ccRCC. Further research is needed to validate PV-1’s prognostic utility, as including it at diagnosis may change the management of these patients and should allow stratification for more aggressive therapies or for closer follow-ups to promptly intervene in case of metastases development.Keywords
Funding Information
- Fondazione AIRC per la ricerca sul cancro ETS (5x1000 2018 ID.21147)
- Fondazione AIRC per la ricerca sul cancro ETS (5x1000 2019 ID.22757)
This publication has 29 references indexed in Scilit:
- Recurrent renal cell cancer: 10 years or more after nephrectomyCanadian Urological Association Journal, 2013
- Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?Clinical & Experimental Metastasis, 2012
- Trends in survival for patients with metastatic soft‐tissue sarcomaCancer, 2010
- Renal cell carcinomaThe Lancet, 2009
- Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesisJournal of Cellular and Molecular Medicine, 2007
- Multiple metastases from renal carcinoma 15 years after nephrectomyNippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2007
- Unusual gastric and pancreatic metastatic renal cell carcinoma presentation 10 years after surgery and immunotherapy: A case report and a review of literature.World Journal of Gastroenterology, 2006
- PV1 Is a Key Structural Component for the Formation of the Stomatal and Fenestral DiaphragmsMolecular Biology of the Cell, 2004
- Single cerebral metastasis 3 and 19 years after primary renal cell carcinoma: case report and review of the literatureJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group StudyJournal of Clinical Oncology, 1999